Selected research
Industry Growth & Trends
Global Biomedical CRO Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Biomedical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Biomedical CRO market include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv and ChemPartner, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Biomedical CRO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biomedical CRO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biomedical CRO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biomedical CRO.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biomedical CRO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biomedical CRO Market by Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON Plc
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology
Biomedical CRO Segment by Type
Preclinical CRO
Clinical CRO
Biomedical CRO Segment by Application
Biological Industry
Medical Industry
Biomedical CRO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomedical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical CRO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biomedical CRO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Preclinical CRO
- Clinical CRO
Applications
- Biological Industry
- Medical Industry
Companies covered
- Charles River
- Wuxi AppTec
- Labcorp
- Eurofins Scientific
- PPD
- ICON Plc
- Pharmaron
- Inotiv
- ChemPartner
- JOINN Lab
- EVOTEC
- Medicilon
- Crown Bioscience
- Champion Oncology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biomedical CRO Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biomedical CRO Market Size by Region (2021-2032)
- 1.4.1 Global Biomedical CRO Market Size by Region (2021-2026)
- 1.4.2 Global Biomedical CRO Market Size by Region (2027-2032)
- 1.5 Key Regions Biomedical CRO Market Size (2021-2032)
- 1.5.1 North America Biomedical CRO Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biomedical CRO Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biomedical CRO Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biomedical CRO Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biomedical CRO Market Size Growth Rate (2021-2032)
2 Biomedical CRO Market by Type
- 2.1 Type Introduction
- 2.1.1 Preclinical CRO
- 2.1.2 Clinical CRO
- 2.2 Global Biomedical CRO Market Size by Type
- 2.2.1 Global Biomedical CRO Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biomedical CRO Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biomedical CRO Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biomedical CRO Market Size by Regions
- 2.3.1 North America Biomedical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biomedical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biomedical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biomedical CRO Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biomedical CRO Market Size Breakdown by Type (2021-2026)
3 Biomedical CRO Market by Application
- 3.1 Type Introduction
- 3.1.1 Biological Industry
- 3.1.2 Medical Industry
- 3.2 Global Biomedical CRO Market Size by Application
- 3.2.1 Global Biomedical CRO Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biomedical CRO Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biomedical CRO Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biomedical CRO Market Size by Regions
- 3.3.1 North America Biomedical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biomedical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biomedical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biomedical CRO Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biomedical CRO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biomedical CRO Industry Trends
- 4.2 Biomedical CRO Industry Drivers
- 4.3 Biomedical CRO Industry Opportunities and Challenges
- 4.4 Biomedical CRO Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biomedical CRO Revenue (2021-2026)
- 5.2 Global Biomedical CRO Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biomedical CRO Key Company Headquarters & Area Served
- 5.4 Global Biomedical CRO Company, Product Type & Application
- 5.5 Global Biomedical CRO Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biomedical CRO Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biomedical CRO Players Market Share by Revenue in 2025
- 5.6.3 2025 Biomedical CRO Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Charles River
- 6.1.1 Charles River Company Information
- 6.1.2 Charles River Business Overview
- 6.1.3 Charles River Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Charles River Biomedical CRO Product Portfolio
- 6.1.5 Charles River Recent Developments
- 6.2 Wuxi AppTec
- 6.2.1 Wuxi AppTec Company Information
- 6.2.2 Wuxi AppTec Business Overview
- 6.2.3 Wuxi AppTec Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Wuxi AppTec Biomedical CRO Product Portfolio
- 6.2.5 Wuxi AppTec Recent Developments
- 6.3 Labcorp
- 6.3.1 Labcorp Company Information
- 6.3.2 Labcorp Business Overview
- 6.3.3 Labcorp Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Labcorp Biomedical CRO Product Portfolio
- 6.3.5 Labcorp Recent Developments
- 6.4 Eurofins Scientific
- 6.4.1 Eurofins Scientific Company Information
- 6.4.2 Eurofins Scientific Business Overview
- 6.4.3 Eurofins Scientific Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Eurofins Scientific Biomedical CRO Product Portfolio
- 6.4.5 Eurofins Scientific Recent Developments
- 6.5 PPD
- 6.5.1 PPD Company Information
- 6.5.2 PPD Business Overview
- 6.5.3 PPD Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PPD Biomedical CRO Product Portfolio
- 6.5.5 PPD Recent Developments
- 6.6 ICON Plc
- 6.6.1 ICON Plc Company Information
- 6.6.2 ICON Plc Business Overview
- 6.6.3 ICON Plc Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 ICON Plc Biomedical CRO Product Portfolio
- 6.6.5 ICON Plc Recent Developments
- 6.7 Pharmaron
- 6.7.1 Pharmaron Company Information
- 6.7.2 Pharmaron Business Overview
- 6.7.3 Pharmaron Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Pharmaron Biomedical CRO Product Portfolio
- 6.7.5 Pharmaron Recent Developments
- 6.8 Inotiv
- 6.8.1 Inotiv Company Information
- 6.8.2 Inotiv Business Overview
- 6.8.3 Inotiv Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Inotiv Biomedical CRO Product Portfolio
- 6.8.5 Inotiv Recent Developments
- 6.9 ChemPartner
- 6.9.1 ChemPartner Company Information
- 6.9.2 ChemPartner Business Overview
- 6.9.3 ChemPartner Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 ChemPartner Biomedical CRO Product Portfolio
- 6.9.5 ChemPartner Recent Developments
- 6.10 JOINN Lab
- 6.10.1 JOINN Lab Company Information
- 6.10.2 JOINN Lab Business Overview
- 6.10.3 JOINN Lab Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 JOINN Lab Biomedical CRO Product Portfolio
- 6.10.5 JOINN Lab Recent Developments
- 6.11 EVOTEC
- 6.11.1 EVOTEC Company Information
- 6.11.2 EVOTEC Business Overview
- 6.11.3 EVOTEC Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 EVOTEC Biomedical CRO Product Portfolio
- 6.11.5 EVOTEC Recent Developments
- 6.12 Medicilon
- 6.12.1 Medicilon Company Information
- 6.12.2 Medicilon Business Overview
- 6.12.3 Medicilon Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Medicilon Biomedical CRO Product Portfolio
- 6.12.5 Medicilon Recent Developments
- 6.13 Crown Bioscience
- 6.13.1 Crown Bioscience Company Information
- 6.13.2 Crown Bioscience Business Overview
- 6.13.3 Crown Bioscience Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Crown Bioscience Biomedical CRO Product Portfolio
- 6.13.5 Crown Bioscience Recent Developments
- 6.14 Champion Oncology
- 6.14.1 Champion Oncology Company Information
- 6.14.2 Champion Oncology Business Overview
- 6.14.3 Champion Oncology Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Champion Oncology Biomedical CRO Product Portfolio
- 6.14.5 Champion Oncology Recent Developments
7 North America
- 7.1 North America Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biomedical CRO Market Size by Country (2021-2026)
- 7.3 North America Biomedical CRO Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biomedical CRO Market Size by Country (2021-2026)
- 8.3 Europe Biomedical CRO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biomedical CRO Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biomedical CRO Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biomedical CRO Market Size by Country (2021-2026)
- 10.3 South America Biomedical CRO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biomedical CRO Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biomedical CRO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst